SCYNEXIS, Inc. Severance Costs
SCYNEXIS, Inc. (SCYX) reported Severance Costs of $1.30 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2024-03-28
- SCYNEXIS, Inc. severance costs for the quarter ending 2014-06-30 was $379.00K.
- SCYNEXIS, Inc. severance costs for fiscal 2022 was $1.30M.
- SCYNEXIS, Inc. severance costs for fiscal 2015 was $2.64M.
- SCYNEXIS, Inc. severance costs for fiscal 2014 was $0.00.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 12 month |
|---|---|---|---|
| 2022-12-31 | $1.30M 10-K · filed 2024-03-28 | ||
| 2015-12-31 | $2.64M 10-K · filed 2016-03-07 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-03-07 | ||
| 2014-06-30 | $379.00K 10-K · filed 2016-03-07 | $379.00K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |